139 related articles for article (PubMed ID: 2942235)
21. [Cancer of the prostate: biologic bases for the use of an antiandrogen in its treatment].
Raynaud JP; Coussediere D; Moguilewsky M; Pottier J; Labrie F
Bull Cancer; 1986; 73(1):36-46. PubMed ID: 3779121
[TBL] [Abstract][Full Text] [Related]
22. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression.
Grant ES; Batchelor KW; Habib FK
Prostate; 1996 Dec; 29(6):339-49. PubMed ID: 8977630
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
24. Testosterone stimulates the primary to secondary follicle transition in bovine follicles in vitro.
Yang MY; Fortune JE
Biol Reprod; 2006 Dec; 75(6):924-32. PubMed ID: 16943368
[TBL] [Abstract][Full Text] [Related]
25. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
[TBL] [Abstract][Full Text] [Related]
26. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
27. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC
Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246
[TBL] [Abstract][Full Text] [Related]
28. Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaP.
Perry JE; Tindall DJ
Cancer Res; 1996 Apr; 56(7):1539-44. PubMed ID: 8603399
[TBL] [Abstract][Full Text] [Related]
29. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha.
Maggiolini M; Donzé O; Jeannin E; Andò S; Picard D
Cancer Res; 1999 Oct; 59(19):4864-9. PubMed ID: 10519397
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
[TBL] [Abstract][Full Text] [Related]
31. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
32. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
Zha S; Ferdinandusse S; Denis S; Wanders RJ; Ewing CM; Luo J; De Marzo AM; Isaacs WB
Cancer Res; 2003 Nov; 63(21):7365-76. PubMed ID: 14612535
[TBL] [Abstract][Full Text] [Related]
33. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
[TBL] [Abstract][Full Text] [Related]
34. Androgenic and antiandrogenic effects and expression of androgen receptor in mouse embryonic stem cells.
Chang CY; Hsuuw YD; Huang FJ; Shyr CR; Chang SY; Huang CK; Kang HY; Huang KE
Fertil Steril; 2006 Apr; 85 Suppl 1():1195-203. PubMed ID: 16616092
[TBL] [Abstract][Full Text] [Related]
35. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context.
Simon S; Mueller SO
Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649
[TBL] [Abstract][Full Text] [Related]
36. Effect of androgen on proliferation of estrogen-responsive transformed mouse Leydig cells in serum-free culture.
Nishizawa Y; Sato B; Nishii K; Kishimoto S; Matsumoto K
Cancer Res; 1989 Mar; 49(6):1377-82. PubMed ID: 2924294
[TBL] [Abstract][Full Text] [Related]
37. The pure antiandrogen RU 23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review.
Raynaud JP; Bonne C; Moguilewsky M; Lefebvre FA; Bélanger A; Labrie F
Prostate; 1984; 5(3):299-311. PubMed ID: 6374639
[TBL] [Abstract][Full Text] [Related]
38. Multiple sensitivities of mammary tumor cells in culture.
Yates J; King RJ
Cancer Res; 1978 Nov; 38(11 Pt 2):4135-7. PubMed ID: 568030
[TBL] [Abstract][Full Text] [Related]
39. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.
Olea N; Sakabe K; Soto AM; Sonnenschein C
Endocrinology; 1990 Mar; 126(3):1457-63. PubMed ID: 2307113
[TBL] [Abstract][Full Text] [Related]
40. Rat prostate cancer cells contain functional receptors for transforming growth factor-beta.
Shain SA; Lin AL; Koger JD; Karaganis AG
Endocrinology; 1990 Feb; 126(2):818-25. PubMed ID: 2153528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
